RxDoctor Payments Data

Samantha Infanti, NP

Nurse Practitioner · Pembroke Pines, FLNPI 1316311814

Payments from drug & device makers

$384in general payments, 2019–2025

Across 18 payments — averaging $21.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim$131
  • Lilly USA, LLC$80
  • AstraZeneca$54
  • Janssen Scientific Affairs, LLC$38
  • Exact Sciences$30
  • Abbott$22
  • plus $29 from 2 others

What the payments were for

  • Food & beverage$384100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$384 in reported general payments places this provider in the 60th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Medicare billing

Part B allowed, 2024
$3,400
Medicare patients
13
Services billed
59

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin86$99,873
EliquisApixaban67$67,819
MounjaroTirzepatide50$55,199
OzempicSemaglutide32$54,152
FarxigaDapagliflozin Propanediol44$40,039
JanuviaSitagliptin Phosphate17$28,743
TrulicityDulaglutide16$21,644
EntrestoSacubitril/Valsartan17$20,849
XareltoRivaroxaban12$15,775
Trelegy ElliptaFluticasone/Umeclidin/Vilanter15$14,831
SynjardyEmpagliflozin/Metformin Hcl21$13,928
TradjentaLinagliptin15$11,543
MyrbetriqMirabegron15$10,362
VascepaIcosapent Ethyl21$9,796
Rosuvastatin Calcium365$4,184

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimJardiance, Synjardy, Tradjenta$131$125,345122 claims
Lilly USA, LLCMounjaro, Trulicity, Humalog$80$78,00483 claims
PfizerEliquis$12$67,81967 claims
AstraZenecaFarxiga, Symbicort$54$43,85255 claims
GSKTrelegy Ellipta$16$14,83115 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Pembroke Pines

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →